Jeffrey Sherrin and Danielle Holley Review Complicated Provisions of New Opioid Law for Clinical Laboratories

Jeffrey Sherrin and Danielle Holley were recently featured in The Dark Daily, an e-brief service focusing on clinical laboratories and pathology groups. In an article discussing the complicated provisions of the new Federal law designed to combat the growing opioid crisis and how it impacts the ways that clinical laboratories may pay sales employees, the […]

Jeff Sherrin and Danielle Holley Present to National Laboratory Leaders

Jeffrey Sherrin was the featured presenter at the 2018 Lab Leaders Forum and Mid-Winter meeting of the National Independent Laboratory Association held on January 26-27 in San Diego. As Legal Counsel for the National Independent Laboratory Association, Jeff conducted two presentations with associate attorney Danielle Holley. The first seminar dealt exclusively with the recently-filed lawsuit […]

Jeff Sherrin Webinar Addresses Legal Issues Laboratories to Face in 2018

Healthcare attorney Jeff Sherrin will be one of three featured speakers during a new Dark Daily webinar on the upcoming Medicare Part B price cuts, and the critical legal and compliance issues facing clinical laboratories and pathology groups in 2018. He’ll be joined by David W. Gee, JD, Partner at Davis Wright Tremaine LLP in […]

Jeffrey J. Sherrin Presents At National Conference for Clinical Laboratories

Jeff Sherrin joins a faculty of 80 lab-industry leaders today at the 22nd Annual Executive War College, billed as the nation’s pre-eminent gathering of senior lab executives, administrators, pathologists and innovators. The 2-day event, held at the Sheraton New Orleans on May 2-3, draws attendance of more than 700. Jeff will conduct general session presentation, […]

FDA Seeks to Regulate Laboratory Developed Tests

On July 31, 2014, the Food and Drug Administration (“FDA”) announced that it would begin regulating laboratory developed tests (LDTs).  According to the FDA, LDTs are designed, manufactured, and used within a single lab, and include some genetic tests and tests that are used by various health care professionals.  These tests are developed by hospitals, academic, […]

Proposed Rule to Extend and Amend the Exception to Donate Electronic Health Records Items and Services

The Office of Inspector General for the Department of Health and Human Services (OIG) and the Centers for Medicare and Medicaid Services (CMS) published on April 10, 2013 proposed rules to extend and amend the Electronic Health Records (EHR) donation exceptions under the Anti-Kickback Statute and Stark Law, respectively. The proposed rules would extend the […]


O’Connell & Aronowitz has for the second time in 3 years recovered millions of dollars for independent and hospital-based clinical laboratories against the New York State Department of Health. Senior healthcare litigator Jeffrey J. Sherrin, whose 2009 trial victory against DOH netted over $5 million, today won an $18 million refund for overpayment of fees […]

Selected Bills before New York State Senate Health Committee for the 2013 Session

A few bills of note for health care providers in New York were introduced in the New York State Senate with the opening of the 2013 legislative session.  Each of these bills was formally introduced on January 9 and referred to the Senate Health Committee. An act allowing patients to see their laboratory results upon […]

HIPAA: Conversion to Version 5010

As of January 1, 2012, all healthcare providers were required to transition from version 4010/4010A to version 5010 standards for submitting electronic transactions, and the failure to comply may result in claim denials or a government investigation. CMS has repeatedly postponed enforcement, but it appears the agency will begin to enforce civil monetary penalties against […]

Legal Hurdles Mount for Lab Corp and Quest

The U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC) recently released their Annual Report for Fiscal Year 2011 under the Hart-Scott-Rodino Antitrust Act. In brief, the Hart-Scott-Rodino Act allows the DOJ and FTC to block transactions believed to be harmful to competition and consumers. The Annual Report reviews the enforcement activities undertaken by these […]